Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
about
In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungiIn vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859aPharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteersDual inhibitory activity of sitafloxacin (DU-6859a) against DNA gyrase and topoisomerase IV of Streptococcus pneumoniaeCloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IVUrinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteersAntibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci.In vitro activity of DU-6859a against anaerobic bacteria.Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.In vitro and in vivo activities of sitafloxacin against Chlamydia sppIn vitro activity of DU-6859a, a new fluorocyclopropyl quinoloneSurvey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciIn vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology.Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteinsHelicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.Current perspectives on glycopeptide resistance.Antimicrobial activity of DV-7751a, a new fluoroquinoloneEvaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections.New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC geneComparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.
P2860
Q28367448-B2886F03-096C-429A-8B9E-34202B7DE28EQ28368060-3BCB56EA-18AC-4FE5-9FC7-314F7FB63E1BQ28368062-C3D9F17F-6BA8-4540-BC36-07D2A7BF7F2AQ28377381-79A99790-FD67-4B74-B802-461682AADB91Q28492734-5D3DD870-695A-4400-84D4-1E2855E4863CQ33694071-4A8F532F-DB05-4FFD-9861-E9F88C940451Q33696363-4CC59BA3-FF15-49E0-9AA8-AE6DA4DE7F82Q33751682-A854131D-B4B1-438A-ACB0-57257D559191Q33757309-5B64E48B-3F84-4EA4-95AC-F2011129D40AQ33762450-4EC3E5E9-B86D-4122-BAAF-762D2FB2263BQ33771929-A14D0550-2803-4A30-BEF7-808B1F10D3F0Q33983352-81B13132-4F49-4233-B829-D856A4F70405Q33983469-CABB0666-ADD5-4B51-A92B-67A4AC0CCFC2Q34727033-576E1BDC-8127-4B70-A96A-4DE7B93F382FQ35111201-71F31235-E112-4440-B053-4451619F7506Q35115957-287AB255-5D80-4C74-A123-A7A5CD2A502AQ35122364-9FA833E2-8DE0-4A6F-B49C-E1CD03719A14Q35125320-6D5D7569-27DB-4B57-8508-8025CD5EC550Q35127493-8A1585F6-13F5-4C0D-8364-4A1766E09B8BQ35129221-217924E5-9CD7-4BB6-AF7D-47406AAA9472Q35132780-F937B585-3925-4695-91E2-BFF9B2E82CD8Q35135289-E6CE399E-0E13-4ED5-9B33-20D9E0C4BFC1Q35138781-8609BBBA-B90C-4BA2-85C4-A14BAC82BCABQ35139054-1F36738B-F698-4E50-B972-6DCDE571AA42Q35191379-B3C0F6D8-35E4-43DD-A69A-5547A8F257DDQ35368590-52A57408-86E6-41B3-9FEA-A5C7B4F87368Q35897320-F4035FE1-1410-419E-BBC1-BC114ABA95A1Q35900223-F3485F33-94E7-4EAF-AD3D-D580AE1A6115Q35900278-08D41E36-D490-4763-ADFA-D4B226866C1EQ37298388-26B1BF11-4F76-4EE1-B6B8-4683A847920DQ38675370-C9590AAB-617E-40FD-B33E-E7FB47421402Q39558046-23C6E006-89E6-40DA-80D7-0F9A56DF1004Q39781097-7D3EB240-6EB3-4B48-8BD1-37FA8EABAEC7Q39781656-199D798B-043E-4201-B48D-4E835862EB5AQ39867252-0D3DC898-FF87-4BC3-812F-D46A477A035DQ40286293-9BA820B4-9E0B-4793-AA04-6331941027EDQ41828456-9584CFE5-E1DB-478B-B536-BF53B17EC9CF
P2860
Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@ast
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@en
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@nl
type
label
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@ast
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@en
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@nl
prefLabel
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@ast
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@en
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@nl
P2093
P2860
P356
P1476
Antimicrobial activity of DU-6 ...... ne, against clinical isolates.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.7.1491
P407
P577
1992-07-01T00:00:00Z